Crinetics Pharmaceuticals, Inc. (CRNX)

Revenue

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023
Product Net Revenue	-	5.42M	-
Collaboration and License Revenue	2.90M	2.28M	1.04M
Revenue (Total)	42.16M	7.70M	1.04M

Data Source: Fiscal.ai Last updated: Aug 3, 2026

Financial data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jan 1, 2000

Data Sources Report a data error